Leading Companies

Novaremed AG

Novaremed is a clinical-stage Swiss biopharmaceutical company focused on the development of NRD.E1, an orally active New Chemical Entity (NCE) for the treatment of Neuropathic Pain. After the relocation to Basel in 2018, Novaremed is currently preparing for a global Phase IIb study in DNP.

Novaremed AG

Elisabethenstrasse 18
4051 Basel
Switzerland


Secteurs
Bio Technology (Biotech)
Life Science
Country of Origin
Israël
En savoir plus sur le sujet
Partager

Partenaire Premium

Partenaires stratégiques

Partenaire institutionnel

Programme officiel